Quick Answer: Found is a real obesity-medicine telehealth platform that combines clinician visits, app-based support, and access to prescription weight-loss medications, including GLP-1 options if you qualify. Its biggest advantage is flexibility: Found supports both insurance-based and self-pay paths, which can make it more affordable than some competitors, but the pricing is not simple enough to judge from one headline number alone.
Found Weight Loss at a Glance
| Feature | Found | What it means in practice | Best for |
|---|---|---|---|
| Entry pricing | Memberships start at $17/month with insurance; self-pay plans also available | Found pushes insurance-first pricing harder than many competitors | People who want to lower total cost using insurance |
| Medication options | 10+ medications including Wegovy, Zepbound, Ozempic, Mounjaro, Saxenda, liraglutide, metformin, Contrave, topiramate, and others | You are not locked into one GLP-1-only model | People who want medication flexibility, not just one branded path |
| Care model | Initial consult, follow-up visits, monthly provider check-ins, prescription adjustments, refills, 24/7 support, app/community tools | Found is selling ongoing treatment management, not just a prescription | Users who want more support than a one-time telehealth visit |
| Insurance positioning | Partners with select health insurers; insurance may cover visits, medications, labs; Found subscription fee not covered | Insurance can lower the clinical-care side, but not every line item disappears | People willing to check coverage carefully before buying |
| GLP-1 pricing examples | Zepbound from $650/month+, Mounjaro around $1,100/month | Real total depends on drug choice, coverage, and plan structure | Shoppers comparing all-in monthly cost rather than ad copy |
What Found Actually Is
Found is best understood as a medical weight-care platform, not just a GLP-1 storefront. The company frames its program around obesity medicine, with clinicians, follow-up visits, app tracking, nutrition guidance, community tools, and a medication toolkit that includes both GLP-1 and non-GLP-1 options. Found is not promising that every user gets one specific drug. It is promising a broader treatment approach that can adapt based on budget, insurance, and clinical fit.
On its site, Found lists medications including Wegovy, Zepbound, Ozempic, Mounjaro, Saxenda, Victoza, metformin, Contrave, topiramate, and others. This is a platform for people who want obesity care with options, not just a single brand-name injection.
How Much Found Costs in 2026
Found’s pricing is more nuanced than it first appears. The company advertises memberships starting at $17 per month with insurance and says many members may only owe a copay for provider visits depending on plan coverage. It also says insurance may cover some or all of visits, medications, labs, and other services, while making clear that the Found subscription fee itself is not covered by insurance.
If you are paying cash, the structure changes. Found says self-pay members can choose Core or Plus plans. The site also shows example medication pricing like Zepbound from $650/month+ and Mounjaro around $1,100/month, while noting that medication selection depends on provider discretion.
The key takeaway: Found can be quite affordable for the right insured person and much less affordable for someone paying cash for a branded GLP-1. Compare total monthly cost based on your actual path — not one teaser number vs another.
What Found Gets Right
Found’s biggest strength is flexibility. Many telehealth weight-loss companies are really built around one lane: either insurance-first or cash-pay convenience. Found tries to do both. It explicitly offers an insurance path, a self-pay path, multiple medication categories, and ongoing clinical management. For someone who does not yet know whether insurance will cover Wegovy or Zepbound, that flexibility is useful.
The second strength is that Found looks more like a true obesity-care program than a simple prescription mill. The program page highlights monthly provider check-ins, prescription adjustments, easy refills, and on-demand support, along with nutrition guidance and app-based habit tracking.
Third, Found has become more current in its medication lineup. The site already includes a page for Foundayo, which it says was FDA-approved on April 1, 2026, for chronic weight management — suggesting Found is moving aggressively to stay current as the anti-obesity medication market expands.
Where Found Is Weaker
Found’s biggest weakness is pricing clarity. The site gives useful signals, but not in the cleanest way for a comparison shopper. You may see “starting at $17/month with insurance,” but that does not mean your medication is basically free. Your actual medication cost and membership total depend on your insurer, your provider’s decision, and the plan type you choose.
The second weakness is that Found still sits inside the same regulatory reality affecting the whole category. Found’s offer terms include compounded GLP-1 plans. The FDA has been increasingly explicit that compounded GLP-1 drugs are not FDA-approved, that the agency does not review them for safety, effectiveness, or quality before marketing, and that it is stepping up enforcement against misleading telehealth marketing around compounded GLP-1s.
Who Should Use Found
Found makes the most sense for someone who wants clinician-led weight care and is open to using insurance if available. If your goal is to find a platform that can help you navigate coverage, prescribe from a wider toolbox, and stay with you through medication changes, Found is a strong contender.
It is also a better fit than some competitors for someone who is not sure a GLP-1 will be the final answer. Because Found uses both GLP-1 and non-GLP-1 medications, it is not as dependent on one expensive drug lane.
It makes less sense if you want the cleanest possible flat-rate consumer experience. Found is more flexible, but flexibility often means more variables.
What to Check Before Signing Up
Before joining Found, check whether it is actually in-network with your plan in your state and what exactly your insurance will cover. Found says coverage varies and that not all states have available plans.
You should also ask whether your likely medication path is branded, generic, or compounded. The FDA has warned consumers to be cautious with unapproved compounded GLP-1 drugs, especially around product sourcing, storage during shipping, and fraudulent labeling.
Verdict
Found is one of the more credible telehealth weight-loss options in 2026 because it is not locked into a single overpriced lane. Seriously consider Found if you have insurance, want real obesity-medicine support, and need flexibility on medication strategy. Be more cautious if you are paying cash and assuming the headline price will reflect your full monthly bill, or if you are being funneled toward compounded GLP-1s without a very clear explanation.
Frequently Asked Questions
Is Found a legit weight-loss company?
Yes. Found is a real telehealth weight-care platform that offers clinician visits, app-based support, and prescription treatment options, including GLP-1 medications if you qualify.
How much does Found cost per month?
Found says memberships start at $17/month with insurance, but total cost varies based on coverage, provider visits, plan type, and medication choice. If you are paying cash, branded GLP-1 costs can be much higher.
Does Found take insurance for GLP-1 weight loss?
Found says yes — it partners with select insurers and insurance may cover provider visits, medications, labs, and other services. The Found subscription fee itself is not covered by insurance.
Does Found prescribe Wegovy or Zepbound?
Yes. Found lists Wegovy and Zepbound among its supported prescription options, alongside Ozempic, Mounjaro, Saxenda, and more.
Does Found offer compounded GLP-1s?
Yes, Found’s offer terms include compounded GLP-1 plans. Because compounded drugs are not FDA-approved, confirm exactly what product you are being offered and why.
Is Found better than a simple GLP-1 subscription service?
It can be, especially if you want insurance navigation, clinician follow-up, and access to more than one medication lane. It may be less appealing if you want a very simple flat-fee purchase flow with fewer variables.